Event Promises to be the Premier Gala Supporting St. Jude in the Capital Region

Net sales of $90 million GAAP net loss of $0.02 per share; Adjusted (Non-GAAP) net income of $0.07 per share Adjusted EBITDA Grows 56% to $12.3 million Operating cash flow of $10.8 million versus $1 million of cash used in prior year Company Introduces Financial Guidance for FY 2014 ALBANY, N.Y.

Company Also Earns Health Canada Clearance for Smart Port Power-Injectable Ports

ALBANY, N.Y. , June 25, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2013 fourth

Pending U.S. Study Parallels European Prostate Efforts

BioFlo Technology Highlighted During Fifth Annual Innovation Celebration

ALBANY, N.Y. , May 28, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at Jefferies 2013 Global Healthcare Conference on Monday,

ALBANY, N.Y. , May 14, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the UBS Global Healthcare Conference on Tuesday, May

Net sales of $81.6 million GAAP net loss of $0.03 per share; Adjusted (Non-GAAP) net income of $0.08 per share Adjusted EBITDA of $12.7 million , or $0.37 per share; 54% growth over Q3 FY12 Operating cash flow of $10 million versus $6.8 million in prior year ALBANY, N.Y.

ALBANY, N.Y. , March 27, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 third quarter financial

ALBANY, N.Y. , March 8, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the Barclays Global Healthcare Conference on Tuesday,

Conference Call Scheduled for March 8, 2013 at 8:30 a.m. ET

ALBANY, N.Y. , Feb. 13, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is scheduled to present at the RBC Capital Markets Global Healthcare Conference

ALBANY, N.Y. , Feb. 1, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today said it has completed the previously announced acquisition of certain

ALBANY, N.Y. , Jan. 23, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it has exercised the option to purchase certain assets of

ALBANY, N.Y. , Jan. 15, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will host an investor and analyst meeting on Wednesday,

Pro forma net sales growth of 3% to $87 million Adjusted (Non-GAAP) Net Income of $0.10 per share; GAAP Net Income of $0.06 per share Adjusted EBITDA of $13.8 million ; or $0.39 per share, a 26% YOY increase Operating cash flow of $11.1 million ALBANY, N.Y. , Jan.

ALBANY, N.Y. , Jan. 3, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology is scheduled to present at the J.P.

ALBANY, N.Y. , Dec. 19, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 second quarter financial

ALBANY, N.Y. , Dec. 17, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of George W.